Product/Composition:- | Capsaicin Topical Creams / Patches |
---|---|
Strength:- | 0.025%, 0.075%, 0.1%, 1% |
Form:- | Topical Creams / Patches |
Reference Brands:- | Zostrix(US) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Capsaicin topical creams and patches activate TRPV1 receptors on nerve endings, causing a temporary pain-sensation and depleting substance P, which reduces pain signals over time. Benefits include targeted relief from neuropathic and musculoskeletal pain, improved mobility, minimal systemic side effects, and effective long-term pain management when used as directed.
Capsaicin topical creams and patches are approved in the EU and US for localized neuropathic and musculoskeletal pain. In the EU, brands like Qutenza and generic formulations are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval is based on extensive clinical data; products like Qutenza (8%) are registered and regulated accordingly. Both regions enforce strict controls, proper labeling, and usage guidelines to ensure safety and efficacy, especially given the potential for skin irritation. For regulatory dossier preparation, compliance, and registration support, visit PharmaTradz. We facilitate seamless market access for capsaicin topical products, adhering to European and American standards.